© 2020 MJH Life Sciences and HCPLive. All rights reserved.
© 2020 MJH Life Sciences™ and HCPLive. All rights reserved.
July 03, 2020
The results echo the previous understanding of MS specialists as well as add to the literature that has been collected thus far from other assessments.
June 09, 2020
Recent studies show efficacy and safety for both lemborexant and ozanimod.
March 20, 2020
Ponesimod reduced fatigue-related symptoms in phase 3 clinical trial.
March 13, 2020
Hospitals are preparing to treat MS patients safely in the wake of fears over the global pandemic.
March 06, 2020
MS patients who experience relapses score significantly lower on the Timed 25-Foot Walk Test.
August 27, 2019
A recent review of claims data from 2006-2016 revealed out-of-pocket costs for patients have increased seven-fold during the 10-year period, from $372 to $2673 annually.
July 15, 2019
Recent study shows that obesity appears to be associated with an increased pediatric MS risk and that obese patients did not respond well to first-line medications.
July 10, 2019
What new drug classes are catching the most traction among clinicians?
July 07, 2019
It may not be the glitziest addition to screening tools, but MRIs have stood out as a care-changing resource.
July 05, 2019
The role of a primary care physician in multiple sclerosis care should be minimal.